UNSPSC 51123704: Bisaramil

This classification denotes an antiarrhythmic agent with the molecular formula C17H23ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) FVT2ESG270, chemically known as syn-3-ethyl-7-methyl-3,7-diazabicyclo(3.3.1)non-9-yl p-chlorobenzoate but more generally known as bisaramil, which bears US NIH Compound Identifier 3033742. Bisaramil most often comes in base and hydrochloride forms. European Medicines Agency schedules Bisaramil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05848MIG.

UNSPSC 51123704 Bisaramil is a Commodity code encompassing emergency medical medications supplied to state and local fire rescue and emergency medical services. State and local governments procure specific injectable pharmaceutical products under this code to support advanced life support protocols, typically in quantities scaled to annual operational demand. The City of Tampa's recent IFB for Advanced Life Support Medications illustrates the scope: the solicitation named four distinct drug line items (Labetalol HCI, Epinephrine 1:10,000, Adenosine, and Diltiazem) with unit counts totaling over 3,500 doses for Tampa Fire Rescue. Issuing bodies under this code include municipal fire departments and emergency medical services divisions, which maintain standing inventory of injectable medications for field protocols. Vendors must meet pharmaceutical-grade specifications, supply-chain requirements (delivery within ten calendar days), minimum shelf life (nine months or more at acceptance), product warranties (365-day defect-free coverage), and regulatory compliance including OSHA Hazard Communication Standards and accessibility documentation to WCAG 2.2 Level AA.

Geographic activity centers on Florida, where Tampa's Hillsborough County procurement shows active demand. The City of Tampa issued an IFB (Solicitation 26P00188) with a response deadline of April 8, 2026, and an estimated contract value of $40,000 for one year with two one-year renewal options and three additional 30-day extension options. The solicitation carried a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount for SLBE participation not to exceed $10,000. Award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening. Vendors should note that state and local opportunities under this code are typically structured as sealed-bid competitive procurements with firm pricing that includes all freight and taxes, and that pharmaceutical suppliers must maintain current regulatory certifications and supply chain capacity to meet short-window delivery and expiration-date management requirements.